TFG Advisers’s Pfizer PFE Stock Holding History

TFG Advisers’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6,319	Closed	-$210K	–	205
2023 Q3	$210K	Buy	6,319 +518	+9%	+$18.3K	0.1%	184
2023 Q2	$213K	Buy	5,801 +419	+8%	+$16.3K	0.1%	188
2023 Q1	$220K	Buy	5,382 +21	+0.4%	+$907	0.11%	186
2022 Q4	$275K	Sell	5,361 -62	-1%	-$2.97K	0.14%	155
2022 Q3	$237K	Buy	5,423 +57	+1%	+$2.77K	0.13%	165
2022 Q2	$281K	Buy	5,366 +34	+0.6%	+$1.73K	0.15%	149
2022 Q1	$276K	Buy	5,332 +88	+2%	+$4.57K	0.13%	163
2021 Q4	$310K	Sell	5,244 -22	-0.4%	-$1.09K	0.14%	157
2021 Q3	$226K	Buy	+5,266	New	+$233K	0.11%	187
2020 Q1	–	Sell	-5,578	Closed	-$207K	–	362
2019 Q4	$207K	Buy	+5,578	New	+$199K	0.12%	161
2019 Q3	–	Sell	-6,276	Closed	-$257K	–	163
2019 Q2	$257K	Buy	6,276 +493	+9%	+$19.6K	0.18%	131
2019 Q1	$233K	Buy	5,783 +92	+2%	+$3.68K	0.17%	138
2018 Q4	$235K	Buy	+5,691	New	+$236K	0.2%	131

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

TFG Advisers's PFE Position: Q4 2023 in Review

TFG Advisers sold out of Pfizer (PFE) in Q4 2023, closing a stake of 6,319 shares — an estimated $210K sold.

TFG Advisers first reported a position in PFE in Q4 2018 and held it in 13 quarters. The position peaked at $310K in Q4 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

TFG Advisers reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
TFG Advisers sold 6,319 Pfizer shares in Q4 2023, an estimated $210K.
TFG Advisers first reported a position in Pfizer in Q4 2018 and held it in 13 quarters.
TFG Advisers's Pfizer position peaked at $310K in Q4 2021.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on TFG Advisers's 13F filing for Q4 2023, filed 13 Feb 2024.